Schizophrenia Research
May 25, 2022
E. Setién-Suero, R. Ayesa‐Arriola, J. Peña et al.
BACKGROUND Attention deficits have been considered to be a central characteristic of schizophrenia-spectrum disorders. However, the specific interactions with, and longitudinal effects of, cannabis use at the different stages of the disorder remain unknown. Due to the high percentage of patients who are cannabis users at the onset of the disease, our objective was to explore this relationship...
Acta Psychiatrica Scandinavica
August 5, 2019
E. Setién-Suero, Karl Neergaard, V. Ortiz-García de la Foz et al.
To examine the long‐term (up to 10 years) patterns related to cannabis use in a sample of patients with first episode of psychosis (FEP) and the effect that consumption might have on clinical, functioning, and neurocognition at long‐term.
Schizophrenia Bulletin
April 1, 2018
E. Setién-Suero, D. Tordesillas-Gutiérrez, B. Crespo-Facorro et al.
Abstract Background In recent years, the effect of cannabis use on cognitive functions in patients with psychosis has been widely studied, but results are somewhat contradictory. On the other hand, it has also been studied the relevance of the age of onset of consume, suggesting that the early age of onset of consumption may be related to a greater cognitive impairment. Methods 349 patients...
PLoS One
August 23, 2017
E. Setién-Suero, Karl Neergaard, M. Ramírez-Bonilla et al.
Background Numerous studies show the existence of a high prevalence of cannabis use among patients with psychosis. However, the differences between men and women who debut with a first episode of psychosis (FEP) regarding cannabis use have not been largely explored. The aim of this study was to identify the specific sex factors and differences in clinical evolution associated with cannabis use....